Market Overview:
The global mebhydrolin market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of allergies, increasing awareness about mebhydrolin and its benefits, and growing demand for over-the-counter drugs. However, the high cost of mebhydrolin may restrain the growth of this market to some extent. Based on type, the global mebhydrolin market can be segmented into hospital and drug store segments. The hospital segment is expected to account for a larger share of the global mebhydrolin market than the drug store segment during the forecast period. This can be attributed to factors such as rising prevalence of allergies and increasing awareness about mebhydrolin among healthcare professionals. Based on application, nasal allergies are expected to account for a larger share of the global mebohydrolin market than allergic dermatosis duringthe forecast period owingto their high prevalence across all regions studied in this research study.
Product Definition:
Mebhydrolin is a prodrug of mebrofenin, which is an anti-inflammatory agent.
Hospital:
Hospital is a chemical intermediate used in the production of drugs and medicines. It is also used as an intermediate during the purification of insulin, construction material for pesticides, herbicides and fungicides, and in some laboratory processes such as protein sequencing & purification. The global market for hospital has been witnessing significant growth over the past few years on account of increasing demand from pharmaceutical industries across various geographies coupled with growing R&D activities related to drug discovery & development.
Drug Store:
Drug store is a facility where pharmaceutical products are purchased and stored for further use. Drug stores are also known as retail drug stores, retail pharmacy, or just pharma shop. They sell medicines to consumers and wholesalers/pharmaceutical distributors directly as well as through third-party distribution agreements.
In the U.S., there are two types of drug stores: Type 1 (brick) and Type 2 (gas).
Application Insights:
The nasal allergies segment held the largest revenue share of over 40.0% in 2017. Nasal sprays, drops and gels are highly effective in treating allergic rhinitis due to their immediate effect on the nose and eyes. The introduction of new products with a faster onset of action is expected to boost the demand for mebhydrolin over the forecast period.
Mebhydrolin is used for treatment of allergic dermatosis which comprises atopic eczema, urticaria (hives), angioedema (swelling) and others such as erythema multiforme major (EM) and temporal hives/ itching skin rash associated with food allergy or drug reaction respectively.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period. This can be attributed to increasing prevalence of allergic disorders, presence of key manufacturers and well-established healthcare infrastructure in this region. In addition, high adoption of new technologies such as digital pharmacy and e-commerce is also contributing towards growth in this region.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rising geriatric population base coupled with increasing disposable income especially in developing economies such as China and India which are major markets for mebhydrolin drug products including nasal sprays & drops & patches respectively. Moreover, growing awareness about various treatment options for common conditions like rhinitis among patients will drive regional market during the forecast years from 2018 to 2030 (Ref).
In addition, government initiatives encouraging generic version sales are further expected boost revenue generation capacity of local players thereby driving competition within regional markets (Ref).
Growth Factors:
- Increasing demand for Mebhydrolin in the pharmaceutical and biotechnology industries for the manufacture of drugs and other products.
- Growing demand from emerging markets such as China and India for Mebhydrolin due to increasing population and rising income levels.
- Rising awareness about the benefits of Mebhydrolin among consumers, which is driving its adoption in a number of applications including cosmetics, food additives, etc.
- Technological advancements that are resulting in new applications for Mebhydrolin across various industries. For instance, it is being increasingly used as a preservative in foods owing to its anti-microbial properties . 5) The increasing use of mebohydrolin by manufacturers as an ingredient in their products is also contributing to market growth
Scope Of The Report
Report Attributes
Report Details
Report Title
Mebhydrolin Market Research Report
By Type
Hospital, Drug Store
By Application
Nasal Allergies, Allergic Dermatosis
By Companies
Farmak, Darnitsa, PT Ifars Pharmaceutical, Sheng Chung Tang, Hua Shin, Shyh Dar, Winston Pharmaceuticals, Medimet Pharmaceuticals, Marbiopharm, Sanbe Farma, Yung Shin, Pyridam Farma, Chin Teng Pharmaceutical, Opsonin Pharma, Eskayef Pharmaceuticals, Pharma Wise, Mediceena Pharma, Chen-ho Pharmaceuticals, March Pharma, Bayer
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
155
Number of Tables & Figures
109
Customization Available
Yes, the report can be customized as per your need.
Global Mebhydrolin Market Report Segments:
The global Mebhydrolin market is segmented on the basis of:
Types
Hospital, Drug Store
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Nasal Allergies, Allergic Dermatosis
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Farmak
- Darnitsa
- PT Ifars Pharmaceutical
- Sheng Chung Tang
- Hua Shin
- Shyh Dar
- Winston Pharmaceuticals
- Medimet Pharmaceuticals
- Marbiopharm
- Sanbe Farma
- Yung Shin
- Pyridam Farma
- Chin Teng Pharmaceutical
- Opsonin Pharma
- Eskayef Pharmaceuticals
- Pharma Wise
- Mediceena Pharma
- Chen-ho Pharmaceuticals
- March Pharma
- Bayer
Highlights of The Mebhydrolin Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Hospital
- Drug Store
- By Application:
- Nasal Allergies
- Allergic Dermatosis
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Mebhydrolin Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Mebhydrolin is a prescription medication used to treat high blood pressure. It works by relaxing and widening the blood vessels, which lowers blood pressure.
Some of the major players in the mebhydrolin market are Farmak, Darnitsa, PT Ifars Pharmaceutical, Sheng Chung Tang, Hua Shin, Shyh Dar, Winston Pharmaceuticals, Medimet Pharmaceuticals, Marbiopharm, Sanbe Farma, Yung Shin, Pyridam Farma, Chin Teng Pharmaceutical, Opsonin Pharma, Eskayef Pharmaceuticals, Pharma Wise, Mediceena Pharma, Chen-ho Pharmaceuticals, March Pharma, Bayer.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Mebhydrolin Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Mebhydrolin Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Mebhydrolin Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Mebhydrolin Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Mebhydrolin Market Size & Forecast, 2018-2028 4.5.1 Mebhydrolin Market Size and Y-o-Y Growth 4.5.2 Mebhydrolin Market Absolute $ Opportunity
Chapter 5 Global Mebhydrolin Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Mebhydrolin Market Size Forecast by Type
5.2.1 Hospital
5.2.2 Drug Store
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Mebhydrolin Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Mebhydrolin Market Size Forecast by Applications
6.2.1 Nasal Allergies
6.2.2 Allergic Dermatosis
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Mebhydrolin Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Mebhydrolin Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Mebhydrolin Analysis and Forecast
9.1 Introduction
9.2 North America Mebhydrolin Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Mebhydrolin Market Size Forecast by Type
9.6.1 Hospital
9.6.2 Drug Store
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Mebhydrolin Market Size Forecast by Applications
9.10.1 Nasal Allergies
9.10.2 Allergic Dermatosis
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Mebhydrolin Analysis and Forecast
10.1 Introduction
10.2 Europe Mebhydrolin Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Mebhydrolin Market Size Forecast by Type
10.6.1 Hospital
10.6.2 Drug Store
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Mebhydrolin Market Size Forecast by Applications
10.10.1 Nasal Allergies
10.10.2 Allergic Dermatosis
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Mebhydrolin Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Mebhydrolin Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Mebhydrolin Market Size Forecast by Type
11.6.1 Hospital
11.6.2 Drug Store
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Mebhydrolin Market Size Forecast by Applications
11.10.1 Nasal Allergies
11.10.2 Allergic Dermatosis
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Mebhydrolin Analysis and Forecast
12.1 Introduction
12.2 Latin America Mebhydrolin Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Mebhydrolin Market Size Forecast by Type
12.6.1 Hospital
12.6.2 Drug Store
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Mebhydrolin Market Size Forecast by Applications
12.10.1 Nasal Allergies
12.10.2 Allergic Dermatosis
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Mebhydrolin Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Mebhydrolin Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Mebhydrolin Market Size Forecast by Type
13.6.1 Hospital
13.6.2 Drug Store
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Mebhydrolin Market Size Forecast by Applications
13.10.1 Nasal Allergies
13.10.2 Allergic Dermatosis
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Mebhydrolin Market: Competitive Dashboard
14.2 Global Mebhydrolin Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Farmak
14.3.2 Darnitsa
14.3.3 PT Ifars Pharmaceutical
14.3.4 Sheng Chung Tang
14.3.5 Hua Shin
14.3.6 Shyh Dar
14.3.7 Winston Pharmaceuticals
14.3.8 Medimet Pharmaceuticals
14.3.9 Marbiopharm
14.3.10 Sanbe Farma
14.3.11 Yung Shin
14.3.12 Pyridam Farma
14.3.13 Chin Teng Pharmaceutical
14.3.14 Opsonin Pharma
14.3.15 Eskayef Pharmaceuticals
14.3.16 Pharma Wise
14.3.17 Mediceena Pharma
14.3.18 Chen-ho Pharmaceuticals
14.3.19 March Pharma
14.3.20 Bayer